Miami Clinical and Translational Science Institute

迈阿密临床与转化科学研究所

• 批准号: 8867315
• 负责人: Ralph L. Sacco
• 金额: $ 334.21万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-06-27 至 2016-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8867315
• 关键词: Affect; Am 80; Bioinformatics; Clinical; Clinical Research; Clinical Sciences; Collaborations; Communities; Community Services; Disease; Faculty; Fostering; Funding; Goals; Health; Health Sciences; Health system; Healthcare; Home environment; Infusion procedures; Institutes; Instruction; Interdisciplinary Study; International; Knowledge; Measures; Minority; Minority Groups; Participant; Patients; Plant Roots; Policies; Predisposition; Procedures; Puerto Rico; Renaissance; Research; Resources; Schools; Science; Scientist; Services; Solid; Speed; Talents; Training; Translational Research; Universities; Work; adverse outcome; design; improved; innovation; meetings; patient population; programs; responsible research conduct; success

University of Miami (UM) is in the midst of an academic and scientific renaissance. At the root of this sweeping transformation is an infusion of exceptional scientific talent with substantial external funding, a rich track record of collaborative team science, and the firsthand knowledge of how to build innovative research programs. The Miami Clinical Translational Science Institute (CTSI) will leverage these strengths to connect clinical and translational science with service and community; foster interdisciplinarity; attract our best and brightest clinician scientists to research; nurture a clinical research workforce, and manage resources to sustain success. With the ultimate goal of improving health, we will catalyze research opportunities to better understand and mitigate the factors that affect susceptibility, progression, and adverse consequence of disease in our majority minority patient population. Interdisciplinary research will be built on solid bidirectional collaboration with our diverse communities. We will harmonize core services into highly functional consolidated platforms with standardized policies and procedures and unified governance bonded by our bioinformatics platform. We will advance research translation in "culturalized" health sciences. We use the term "culturalize" to denote that, in a community that is 80% racial/ethnic minorities, our work is exposed to and influenced by the culture of our highly diverse faculty, staff, patients, and study participants. We will leverage the benefits of our CITI program, which remains the international standard for training in responsible conduct of research. We have designed the modern form-meets-function Research Commons, the physical home of the CTSI. Collaboration is high across the CTSI, including partnerships among UM Schools, Jackson Health System, Miami VA and the University of Puerto Rico. Ultimately, the measure of our success will be our ability to improve the health of our community.

迈阿密大学（UM）正处于学术和科学复兴的中期。从根本上说， 全面的转型是一个特殊的科学人才与大量的外部资金，丰富的 合作团队科学的跟踪记录，以及如何建立创新研究的第一手知识 程序.迈阿密临床转化科学研究所（CTSI）将利用这些优势， 临床和转化科学与服务和社区;促进跨学科;吸引我们最好的， 最聪明的临床科学家进行研究;培养临床研究人员，并管理资源， 保持成功。随着改善健康的最终目标，我们将催化研究机会，以更好地 了解并减轻影响易感性、进展和不良后果的因素， 在我们的大多数少数民族患者群体中。跨学科研究将建立在坚实的双向 与我们不同的社区合作。我们将把核心服务整合到功能强大的 统一的平台，标准化的政策和程序以及统一的治理， 生物信息学平台我们将推进“文化化”健康科学的研究翻译。公司现采用国际 “文化化”一词是指，在一个80%是少数种族/民族的社区，我们的工作暴露在 并受到我们高度多样化的教师，员工，患者和研究参与者的文化的影响。我们将 利用我们的CITI计划的好处，这仍然是培训的国际标准， 负责任地进行研究。我们设计了现代形式满足功能的研究共享空间， CTSI的物理家。整个CTSI的协作程度很高，包括UM之间的伙伴关系 学校，杰克逊卫生系统，迈阿密弗吉尼亚州和波多黎各大学。最终， 我们的成功将取决于我们改善社会健康的能力。